- Synthetic Adhesion Barrier
- Regenerated Cellulose
- Hyaluronic Acid
- Polyethylene Glycol
- Others
- Natural Adhesion Barrier
- Fibrin
- Collagen and Protein
Adhesion Barrier Market size was valued at USD 549 million in 2022 and is poised to grow at a CAGR of 7.4% from 2023-29. An adhesion barrier is a medical device used to avoid adhesion occurring during surgery. The adhesion barrier reduces abnormal internal scarring by separating organs and internal tissues. The formation of adhesion causes infertility, chronic pain, and bowel obstruction. These barriers are prepared from natural or synthetic sources and the applications include gynecological and abdominal. Cardiovascular, orthopedic, urological, and reconstructive surgeries. The expansion of this market is being fueled by an increase in the number of surgeries and sports-related injuries, as well as an increase in the geriatric population and increased awareness of adhesion formation and adhesion-related disorders. However, due to the COVID-19 pandemic, this market is currently experiencing a slight slowdown in growth due to a decrease in the number of surgical procedures performed to protect patients. However, as the global economy returns to normal, the number of surgical treatments on hold will gradually increase. Despite the concerns, surgeons are hesitant to utilize adhesion barriers due to a lack of/limited solid clinical evidence confirming the safety and efficacy of commercialized adhesion barrier solutions. Companies also have a hard time getting marketing authorization for their products due to concerns about the safety and efficacy of adhesion barriers. In addition, due to poor clinical outcomes, licensed adhesion barrier treatments have been phased out of the market in recent years. New adhesion barriers necessitate significant expenditure and new products typically take more than 7-8 years to get marketing approval. The cost and time it takes for a product to undergo clinical trials and then pass those studies is quite high, with only a small possibility of the product receiving approval.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the number of geriatric population coupled with rise in number of cardiovascular and gynecological surgeries are expected to drive the adhesion barrier market over the future years. Moreover, increase in the awareness about the usage of surgical barrier in the developed and developing nations, development of low cost products by the market players, increase in the number of sports injuries, and surge in the prevalence of chronic diseases are anticipated to propel the adhesion barrier market over the forecast timeframe. However, stringent regulations for the product approval, increase in the adoption of minimally invasive surgical procedures such as laparoscopic surgeries, and limited applications of the product are hamper the growth of the market.
The Adhesion Barrier Market Size was valued at USD 549 million in 2022
The Adhesion Barrier Market Key Players are Baxter International Inc. (U.S.) Integra LifeSciences Holdings Corporation (U.S.) R. Bard Inc. (U.S.) Johnson & Johnson Services, Inc. (U.S.) MAST Biosurgery AG (Switzerland) Terumo Corporation (Japan) FzioMed Inc. (U.S.) BMI Korea Co. (South Korea)
North America is the fastest-growing Adhesion Barrier Market